Orphanet: A Randomized, Multicenter, Open label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma Phase II FR
x

Search for a clinical trial

* (*) mandatory field

A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma (Phase II) - FR

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : -
  • Sponsor : Centre léon bérard
  • Website
    • Phase : II
Last update: December 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.